背景:头晕和眩晕可由各种因素引起,如外周前庭和中枢疾病。尽管必要时建议与专家协商,有严重眩晕症状的患者可能活动受限,这可能会干扰医院就诊。COVID-19的传播进一步限制了头晕患者的住院次数;因此,需要一种能够在时间和地理限制下进行更准确治疗的医疗方法。远程医疗已经普及,由于近年来智能手机和平板设备的普及,设备和系统的使用使提供有效的医疗成为可能。然而,以前的范围审查没有绘制现有的眩晕和头晕远程医疗研究,并且没有关于哪些设备和系统应该用于特定疾病的建议。
目的:这篇综述的目的是绘制和评估以前关于使用信息通信技术的研究,智能手机,以及用于治疗眩晕患者的应用程序,并讨论引入远程医疗以提高医疗质量并创造在患者之间建立安全和信任的环境的附加值。
方法:根据Arksey和O\'Malley的方法学框架,并根据PRISMA-ScR(系统评价的首选报告项目和范围评价的荟萃分析扩展)指南进行范围审查。PubMed,MEDLINE,和Cochrane图书馆数据库进行检索,以检索以前发表于2000年1月至2023年5月期间的智能手机辅助远程医疗治疗眩晕的报告.两位作者独立评估资格并提取数据。
结果:这篇综述包括20篇论文,报道了用于前庭功能障碍的远程医疗设备或系统。在报告使用设备或应用程序的研究中,2与回忆和主观症状有关,12个与客观考试有关,7与远程诊断有关,7例与治疗和康复有关。
结论:随着技术的进步,在头晕患者中使用远程医疗可能是可行的。在未来,有必要考虑如何将远程医疗用于头晕治疗,并开发一种有效的治疗系统,将现场医疗和有效使用设备相结合,以管理严重眩晕和相关疾病。在眩晕治疗中顺利引入远程医疗有望提高治疗质量,增加患者接受医疗护理的机会,并减少时间和旅行成本,导致患者之间的安全感和信任感。
Dizziness and vertigo can be caused by various factors, such as peripheral vestibular and central disorders. Although consultations with specialists are advisable when necessary, patients with severe vertigo symptoms may have limited mobility, which may interfere with hospital visits. The spread of COVID-19 has further limited the number of hospital visits for patients with dizziness; therefore, a method of medical care that enables more accurate treatment under time and geographical constraints is needed. Telemedicine has become widespread, owing to the popularity of smartphone and tablet devices in recent years, and the use of devices and systems has made it possible to provide efficient medical care. However, no previous scoping
review has mapped existing studies on telemedicine for vertigo and dizziness, and no recommendations have been made regarding which devices and systems should be used for specific diseases.
The aim of this
review was to map and assess previous studies on the use of information communications technology, smartphones, and apps for treating patients with vertigo and discuss the added value of introducing telemedicine to improve the quality of medical care and create an environment that builds security and trust among patients.
A scoping
review was conducted with the methodological framework of Arksey and O\'Malley and in accordance with the of the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analysis extension for Scoping Reviews) guidelines. The PubMed, MEDLINE, and Cochrane Library databases were searched to retrieve previous reports on smartphone-assisted telemedicine treatment for vertigo published between January 2000 and May 2023. Two authors independently assessed eligibility and extracted data.
This
review included 20 papers that reported devices or systems for telemedicine for vestibular dysfunction. Among studies that reported the use of a device or app, 2 were related to anamnesis and subjective symptoms, 12 were related to objective examination, 7 were related to remote diagnosis, and 7 were related to treatment and rehabilitation.
With the advancement of technology, the use of telemedicine in patients with dizziness may be feasible. In the future, it will be necessary to consider how telemedicine can be used in dizziness treatment and develop an effective treatment system combining in-person medical care and the effective use of devices for the management of severe vertigo and related diseases. The smooth introduction of telemedicine in vertigo treatment is expected to improve the quality of treatment, increase opportunities for patients to receive medical care, and reduce time and travel costs, leading to a sense of security and trust among patients.